Surface Oncology to Participate in the 3rd Annual Evercore ISI HealthCONx Conference

    NEXT STORY
    Ascendis Pharma A/S Announces Participation at the Evercore ISI 3rd Annual HealthCONx Virtual Conference
    PREV STORY
    AIM Announces Milestone in COVID-19 Treatment and Prevention Efforts with First Patient Dosed in Study Evaluating Ampligen as Part of Combination Treatment for Patients with Cancer and COVID-19
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Trinity Biotech plc to Announce Second Quarter Fiscal Year 2019 Financial Results

    author_avatar
    NASDAQ Market News

    AB Science Presents Phase 2B/3 Study Results in Progressive Multiple Sclerosis at the World’s Largest Multiple Sclerosis Research Conference

    author_avatar
    NASDAQ Market News

    Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological and Solid Tumors

    author_avatar
    NASDAQ Market News